Chemoinformaics analysis of 3-CYCLOPENTYLPROPIONIC ACID, HEXYL ESTER
| Molecular Weight | 226.36 | nRot | 8 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 6 |
| Exact Molecular Weight | 226.193 | nRing | 1 |
| Solubility: LogS | -5.512 | nHRing | 0 |
| Solubility: LogP | 5.196 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 42.3206 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.46 |
| Synth | 1.866 |
| Natural Product Likeliness | 0.219 |
| NR-PPAR-gamma | 0.034 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.732 |
| Pgp-sub | 0.005 |
| HIA | 0.002 |
| CACO-2 | -4.586 |
| MDCK | 0.000026 |
| BBB | 0.344 |
| PPB | 0.965804 |
| VDSS | 0.927 |
| FU | 0.018259 |
| CYP1A2-inh | 0.923 |
| CYP1A2-sub | 0.259 |
| CYP2c19-inh | 0.739 |
| CYP2c19-sub | 0.093 |
| CYP2c9-inh | 0.564 |
| CYP2c9-sub | 0.841 |
| CYP2d6-inh | 0.18 |
| CYP2d6-sub | 0.098 |
| CYP3a4-inh | 0.572 |
| CYP3a4-sub | 0.13 |
| CL | 8.888 |
| T12 | 0.381 |
| hERG | 0.206 |
| Ames | 0.005 |
| ROA | 0.032 |
| SkinSen | 0.943 |
| Carcinogencity | 0.156 |
| EI | 0.975 |
| Respiratory | 0.578 |
| NR-Aromatase | 0.038 |
| Antiviral | Yes |
| Prediction | 0.73956 |